Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02WST
|
|||
Former ID |
DIB009429
|
|||
Drug Name |
Unfractionated heparin
|
|||
Synonyms |
Elaprin; UFH (solid oral), Emisphere; Unfractionated heparin (solid oral, eligen); SNAC/heparin capsule (solid oral), Emisphere; SNAD/heparin tablet (solid oral), Emisphere; Unfractionated heparin (solid oral, eligen), Emisphere
Click to Show/Hide
|
|||
Indication | Thrombosis [ICD-11: DB61-GB90; ICD-10: I80-I82] | Phase 3 | [1] | |
Company |
Emisphere Technologies Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Antithrombin-III (ATIII) | Target Info | Modulator | [2] |
KEGG Pathway | Complement and coagulation cascades | |||
Panther Pathway | Blood coagulation | |||
Pathway Interaction Database | Glypican 1 network | |||
Reactome | Intrinsic Pathway of Fibrin Clot Formation | |||
Common Pathway of Fibrin Clot Formation | ||||
WikiPathways | Complement and Coagulation Cascades | |||
Formation of Fibrin Clot (Clotting Cascade) |
References | Top | |||
---|---|---|---|---|
REF 1 | Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. Am Heart J. 2002 Feb;143(2):229-34. | |||
REF 2 | Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma. Thromb Res. 1982 Nov 15;28(4):487-97. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.